Ignite Creation Date:
2024-05-05 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 9:44 AM
Study NCT ID:
NCT00610597
Status:
COMPLETED
Last Update Posted:
2008-02-08
First Post:
2008-01-28
Brief Title:
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
Sponsor:
Erasme University Hospital
Organization:
Erasme University Hospital
Study Overview
Official Title:
Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Alcoholic liver disease is characterized by circulating T cell activation and liver T cell infiltration but their phenotype is poorly studied The aim of the study is to test the hypothesis that the CD4 T cell secreting Interleukin-17 Th17 pathway is involved in alcoholic liver disease
Detailed Description:
Consecutive patients undergoing transjugular liver biopsies for alcoholic liver disease or hepatitis C virus infection will be included in the study to measure plasma cytokines levels peripheral blood mononuclear cells cytokine release and liver T cell infiltrates
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| AL-ALD | None | None | None |